Live Markets
Wednesday, July 29, 2026·George Town, KY·29°·Partly Cloudy
Markets Open · NYSE·Newsletter·Masthead·
VOL. XII · NO. 117Established MMXIV · George Town, Grand CaymanAtlantic Edition · $4.50

The Cayman Journal

Finance · Business · Technology · Caribbean & Global Affairs
13F HOLDINGS REPORT

Propel Bio Management, LLC

Quarter ended Q3 2025 · Filed November 12, 2025 · Accession 0000898432-25-000886

Total Value
$99.9M
Positions
16
Other Managers
1
Confidential Omitted
No
View on SEC.gov

Holdings (16)

#IssuerTicker / CUSIPSharesValue% of Filing
1PLAINS GP HOLDINGS LP-CLPAGP1,272,360$23.2M23.23%
2ACHIEVE LIFE SCIENCES INCACHV3,786,425$11.9M11.94%
3AKERO THERAPEUTICS INC00973Y108228,884$10.9M10.88%
4MILESTONE PHARMACEUTICALSMIST5,124,890$10.2M10.26%
5APPLIED THERAPEUTICS INC03828A10111,285,420$6.8M6.83%
6PHATHOM PHARMACEUTICALS IPHAT552,927$6.5M6.51%
7ABEONA THERAPEUTICS INCABEO974,022$5.1M5.15%
8DELCATH SYSTEMS INCDCTH438,509$4.7M4.72%
9CELLDEX THERAPEUTICS INCCLDX155,000$4.0M4.01%
10TSCAN THERAPEUTICS INCTCRX1,932,304$3.5M3.52%
11COMPASS PATHWAYS PLCCMPS510,000$2.9M2.93%
12NEKTAR THERAPEUTICSNKTR49,000$2.8M2.79%
13JASPER THERAPEUTICS INCJSPRW1,028,806$2.4M2.45%
14ZEVRA THERAPEUTICS INCZVRA231,874$2.2M2.21%
15VIRIDIAN THERAPEUTICS INCVRDN90,000$1.9M1.94%
16ATHIRA PHARMA INC04746L203149,279$618,0150.62%